Ayotte calls for immigration reform
Rob Davidson, a genetic engineer at Merck’s GlycoFi in Lebanon, explains the facility’s processes to U.S. Sen. Kelly Ayotte during a tour of the facility on Thursday. (MEGHAN PIERCE/Union Leader Correspondent)
Ayotte met with employees of Merck’s GlycoFi facility and said meeting employees with diverse backgrounds reminded her of the importance of immigration reform, which she supported earlier this year, she said.
The tours were a continuation of the other statewide business tours that she started in August, she said, as part of an effort to engage New Hampshire businesses in a dialogue and focusing on ways to help Granite State businesses succeed and grow.
“The Assad regime did use chemical weapons against its own people. The evidence is very strong that they used the weapons. It wasn’t the opposition or some other group that used these weapons. … Obviously the use of chemical weapons is deplorable. The question now is what should be done about it,” she said. “I still have some substantial questions (such as) if we do take military action, what is the plan? and what do we hope to accomplish? And will we be able to deter him from further using these chemical weapons? or would it potentially exacerbate the situation in the region by taking military action?”
Natarajan Sethuraman, executive director at Merck’s GlycoFi, asked Ayotte if there was a possibility that high-speed train service would be extended from Boston to Lebanon, where it could benefit industry. Merck’s GlycoFi employees often travel to other Merck facilities across the East Coast, including New Jersey.
The company develops yeast-based technology used in the creation of drugs.
The company was acquired by Merck in 2006. It employs 44 people.
Manchester superintendent kills controversial redistricting plan following parental opposition
Win tickets to see Comedian Mike Birbiglia!
Marijuana seller target of robbery